M2Bio Sciences & Juvenescence - 7. The Potential of the Medical Psychedelics | Rob Schwartz, CEO, Anterix IncATEX:NAQ 00:10:00
Rob Joined our board in September 2020 and has served as President & CEO of Anterix since July 2020. He joined the company in 2015 as Chief Strategy and Development Officer and was named President and COO in 2018. Prior to Anterix, Rob was the CEO of STI Brasil, LLC, where he focused on developing shared fiber infrastructure for wireless operations in Brazil. As a Managing Director of Unison Site Management, Rob led key strategic initiatives to help build and then sell one of Unison’s site portfolios to American Tower. Prior to Unison, Rob served as EVP of IDT Telecom, where he led corporate development, product management, and the wireless division. Rob has also held a senior management role at The Associated Group, where he helped launch Teligent, and led functions including strategy, capital markets, and investor relations through the sale of the company to Liberty Media.